IL17A and Alzheimer disease: AD is a T cell-mediated chronic skin disease, affecting up to 20% of children worldwide, its onset is associated with skin barrier dysfunction and immune disorder (205), it is characterized by highly expanded dermal αβ T cells which produce IL-17 and IL-22 (206), patients suffered from AD also present decreased proportion of γδ T cells (207).